[ARS] ENDRA Life Sciences Inc. SEC Filing

Filing Impact

(No impact)

Filing Sentiment

(Neutral)

Form Type

ARS

10/28/2025 - 07:10 AM

Source: View Original Filing on SEC EDGAR

Endra Life Sciences Inc

NASDAQ:NDRA

NDRA Rankings

#6370 Ranked by Market Cap

N/A Ranked by Dividends

NDRA Latest News

Oct 23, 2025

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Oct 13, 2025

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

Aug 14, 2025

ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results

Jun 16, 2025

ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

May 15, 2025

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

NDRA Latest SEC Filings

Oct 28, 2025

[DEF 14A] ENDRA Life Sciences Inc. Definitive Proxy Statement

Oct 23, 2025

[8-K] ENDRA Life Sciences Inc. Reports Material Event

Oct 17, 2025

[PRE 14A] ENDRA Life Sciences Inc. Preliminary Proxy Statement

Oct 15, 2025

[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity

Oct 15, 2025

[8-K/A] – ENDRA Life Sciences Inc. (NDRA) (CIK 0001681682)

NDRA Stock Data

Market Cap 7.93M

Float 665.00k

Insiders Ownership 2.25%

Institutions Ownership 0.63%

Short Percent 13.65%

Industry Diagnostics & Research

Sector Electromedical & Electrotherapeutic Apparatus

Website Link

Country United States

City ANN ARBOR